These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9855356)
1. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion. Azeh I; Mäder M; Smirnov A; Beuche W; Nau R; Weber F Neurosci Lett; 1998 Nov; 256(3):127-30. PubMed ID: 9855356 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. Kolb SA; Lahrtz F; Paul R; Leppert D; Nadal D; Pfister HW; Fontana A J Neuroimmunol; 1998 Apr; 84(2):143-50. PubMed ID: 9628456 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Conant K; McArthur JC; Griffin DE; Sjulson L; Wahl LM; Irani DN Ann Neurol; 1999 Sep; 46(3):391-8. PubMed ID: 10482270 [TBL] [Abstract][Full Text] [Related]
4. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Rosenberg GA; Dencoff JE; Correa N; Reiners M; Ford CC Neurology; 1996 Jun; 46(6):1626-32. PubMed ID: 8649561 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis. Destache CJ; Pakiz CB; Dash AK; Larsen C Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112 [TBL] [Abstract][Full Text] [Related]
6. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Friedberg MH; Glantz MJ; Klempner MS; Cole BF; Perides G Cancer; 1998 Mar; 82(5):923-30. PubMed ID: 9486583 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of matrix metalloproteinases in bacterial meningitis. Kieseier BC; Paul R; Koedel U; Seifert T; Clements JM; Gearing AJ; Pfister HW; Hartung HP Brain; 1999 Aug; 122 ( Pt 8)():1579-87. PubMed ID: 10430840 [TBL] [Abstract][Full Text] [Related]
8. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children. Lindberg RL; Sorsa T; Tervahartiala T; Hoffmann F; Mellanen L; Kappos L; Schaad UB; Leib SL; Leppert D Neuropathol Appl Neurobiol; 2006 Jun; 32(3):304-17. PubMed ID: 16640649 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. Perides G; Charness ME; Tanner LM; Péter O; Satz N; Steere AC; Klempner MS J Infect Dis; 1998 Feb; 177(2):401-8. PubMed ID: 9466528 [TBL] [Abstract][Full Text] [Related]
10. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329 [TBL] [Abstract][Full Text] [Related]
11. Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone. Böttcher T; Ren H; Goiny M; Gerber J; Lykkesfeldt J; Kuhnt U; Lotz M; Bunkowski S; Werner C; Schau I; Spreer A; Christen S; Nau R J Neurochem; 2004 Dec; 91(6):1450-60. PubMed ID: 15584921 [TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. Umehara F; Okada Y; Fujimoto N; Abe M; Izumo S; Osame M J Neuropathol Exp Neurol; 1998 Sep; 57(9):839-49. PubMed ID: 9737547 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401 [TBL] [Abstract][Full Text] [Related]
14. Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. Ernst JD; Decazes JM; Sande MA Infect Immun; 1983 Jul; 41(1):275-9. PubMed ID: 6862627 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloprotease-9 in cerebrospinal fluid correlates with disease activity in lymphomatous meningitis. Wong ET; Lee D; Tam A; Gautam S; Wu JK Clin Lymphoma Myeloma; 2007 Jan; 7(4):305-8. PubMed ID: 17324339 [TBL] [Abstract][Full Text] [Related]
16. Influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis. Østergaard C; O'Reilly T; Brandt C; Frimodt-Møller N; Lundgren JD BMC Infect Dis; 2006 Apr; 6():78. PubMed ID: 16643642 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. Meli DN; Christen S; Leib SL J Infect Dis; 2003 May; 187(9):1411-5. PubMed ID: 12717622 [TBL] [Abstract][Full Text] [Related]
18. Progression of hearing loss in experimental pneumococcal meningitis: correlation with cerebrospinal fluid cytochemistry. Bhatt SM; Lauretano A; Cabellos C; Halpin C; Levine RA; Xu WZ; Nadol JB; Tuomanen E J Infect Dis; 1993 Mar; 167(3):675-83. PubMed ID: 8440938 [TBL] [Abstract][Full Text] [Related]
19. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis. Liu X; Han Q; Sun R; Li Z Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903 [TBL] [Abstract][Full Text] [Related]
20. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis. Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]